aluates Reports

$ 0.0

Automative

Global Chronic Obstructive Pulmonary Disease Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-39O5893

Global Chronic Obstructive Pulmonary Disease Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Chronic Obstructive Pulmonary Disease Market Insights, Forecast to 2029

Code: QYRE-Auto-39O5893

Report

August 2023

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

GSK

MSD

Sunovion

Novartis

Roche Group

Pfizer Inc

Jubilant Pharma Limited

Almirall

Horizon Pharma

Boehringer Ingelheim

Chronic Obstructive Pulmonary Disease Market Size

The global Chronic Obstructive Pulmonary Disease market is projected to grow from US$ 4113.4 million in 2023 to US$ 4816.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.7% during the forecast period.

Chronic Obstructive Pulmonary Disease Market

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult .Chronic bronchitis and emphysema are older terms used for different types of COPD.

Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease Market

Globally the market for COPD is increasing rapidly. The major factor that derives the growth of COPD is the increasing growth in smoking in adults. Furthermore increasing pollution in the environment and increasing asthma patients are increasing the growth of COPD market.

Report Includes

This report presents an overview of global market for Chronic Obstructive Pulmonary Disease market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Chronic Obstructive Pulmonary Disease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Chronic Obstructive Pulmonary Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chronic Obstructive Pulmonary Disease revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Chronic Obstructive Pulmonary Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Chronic Obstructive Pulmonary Disease revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca, GSK, MSD, Sunovion, Novartis, Roche Group, Pfizer, Jubilant Pharma Limited and Almirall, etc.

Scope of Chronic Obstructive Pulmonary Disease Market Report

Report Metric	Details
Report Name	Chronic Obstructive Pulmonary Disease Market
Accounted market size in 2023	US$ 4113.4 million
Forecasted market size in 2029	US$ 4816.6 million
CAGR	2.7
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Bronchodilators Glucocorticoids Other
Segment by Application	Prevention Diagnostic Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, GSK, MSD, Sunovion, Novartis, Roche Group, Pfizer, Jubilant Pharma Limited, Almirall, Horizon Pharma, Boehringer Ingelheim
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Chronic Obstructive Pulmonary Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Obstructive Pulmonary Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Obstructive Pulmonary Disease revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Chronic Obstructive Pulmonary Disease Market growing?

Ans: The Chronic Obstructive Pulmonary Disease Market witnessing a CAGR of 2.7 during the forecast period 2023-2029.

What is the Chronic Obstructive Pulmonary Disease Market size in 2029?

Ans: The global Chronic Obstructive Pulmonary Disease market is projected to grow from US$ 4113.4 million in 2023 to US$ 4816.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.7% during the forecast period.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Bronchodilators

1.2.3 Glucocorticoids

1.2.4 Other

1.3 Market by Application

1.3.1 Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Prevention

1.3.3 Diagnostic

1.3.4 Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Obstructive Pulmonary Disease Market Perspective (2018-2029)

2.2 Global Chronic Obstructive Pulmonary Disease Growth Trends by Region

2.2.1 Chronic Obstructive Pulmonary Disease Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Chronic Obstructive Pulmonary Disease Historic Market Size by Region (2018-2023)

2.2.3 Chronic Obstructive Pulmonary Disease Forecasted Market Size by Region (2024-2029)

2.3 Chronic Obstructive Pulmonary Disease Market Dynamics

2.3.1 Chronic Obstructive Pulmonary Disease Industry Trends

2.3.2 Chronic Obstructive Pulmonary Disease Market Drivers

2.3.3 Chronic Obstructive Pulmonary Disease Market Challenges

2.3.4 Chronic Obstructive Pulmonary Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Chronic Obstructive Pulmonary Disease by Players

3.1.1 Global Chronic Obstructive Pulmonary Disease Revenue by Players (2018-2023)

3.1.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Players (2018-2023)

3.2 Global Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Chronic Obstructive Pulmonary Disease, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Chronic Obstructive Pulmonary Disease Market Concentration Ratio

3.4.1 Global Chronic Obstructive Pulmonary Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease Revenue in 2022

3.5 Global Key Players of Chronic Obstructive Pulmonary Disease Head office and Area Served

3.6 Global Key Players of Chronic Obstructive Pulmonary Disease, Product and Application

3.7 Global Key Players of Chronic Obstructive Pulmonary Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disease Breakdown Data by Type

4.1 Global Chronic Obstructive Pulmonary Disease Historic Market Size by Type (2018-2023)

4.2 Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2024-2029)

5 Chronic Obstructive Pulmonary Disease Breakdown Data by Application

5.1 Global Chronic Obstructive Pulmonary Disease Historic Market Size by Application (2018-2023)

5.2 Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Chronic Obstructive Pulmonary Disease Market Size (2018-2029)

6.2 North America Chronic Obstructive Pulmonary Disease Market Size by Type

6.2.1 North America Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023)

6.2.2 North America Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029)

6.2.3 North America Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

6.3 North America Chronic Obstructive Pulmonary Disease Market Size by Application

6.3.1 North America Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023)

6.3.2 North America Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029)

6.3.3 North America Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

6.4 North America Chronic Obstructive Pulmonary Disease Market Size by Country

6.4.1 North America Chronic Obstructive Pulmonary Disease Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Chronic Obstructive Pulmonary Disease Market Size by Country (2018-2023)

6.4.3 North America Chronic Obstructive Pulmonary Disease Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Chronic Obstructive Pulmonary Disease Market Size (2018-2029)

7.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Type

7.2.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023)

7.2.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029)

7.2.3 Europe Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

7.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Application

7.3.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023)

7.3.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029)

7.3.3 Europe Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

7.4 Europe Chronic Obstructive Pulmonary Disease Market Size by Country

7.4.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2018-2023)

7.4.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Chronic Obstructive Pulmonary Disease Market Size (2018-2029)

8.2 China Chronic Obstructive Pulmonary Disease Market Size by Type

8.2.1 China Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023)

8.2.2 China Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029)

8.2.3 China Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

8.3 China Chronic Obstructive Pulmonary Disease Market Size by Application

8.3.1 China Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023)

8.3.2 China Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029)

8.3.3 China Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Chronic Obstructive Pulmonary Disease Market Size (2018-2029)

9.2 Asia Chronic Obstructive Pulmonary Disease Market Size by Type

9.2.1 Asia Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023)

9.2.2 Asia Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029)

9.2.3 Asia Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

9.3 Asia Chronic Obstructive Pulmonary Disease Market Size by Application

9.3.1 Asia Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023)

9.3.2 Asia Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029)

9.3.3 Asia Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

9.4 Asia Chronic Obstructive Pulmonary Disease Market Size by Region

9.4.1 Asia Chronic Obstructive Pulmonary Disease Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Chronic Obstructive Pulmonary Disease Market Size by Region (2018-2023)

9.4.3 Asia Chronic Obstructive Pulmonary Disease Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Type

10.2.1 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Application

10.3.1 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Country

10.4.1 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Introduction

11.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.1.5 AstraZeneca Recent Developments

11.2 GSK

11.2.1 GSK Company Details

11.2.2 GSK Business Overview

11.2.3 GSK Chronic Obstructive Pulmonary Disease Introduction

11.2.4 GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.2.5 GSK Recent Developments

11.3 MSD

11.3.1 MSD Company Details

11.3.2 MSD Business Overview

11.3.3 MSD Chronic Obstructive Pulmonary Disease Introduction

11.3.4 MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.3.5 MSD Recent Developments

11.4 Sunovion

11.4.1 Sunovion Company Details

11.4.2 Sunovion Business Overview

11.4.3 Sunovion Chronic Obstructive Pulmonary Disease Introduction

11.4.4 Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.4.5 Sunovion Recent Developments

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Chronic Obstructive Pulmonary Disease Introduction

11.5.4 Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.5.5 Novartis Recent Developments

11.6 Roche Group

11.6.1 Roche Group Company Details

11.6.2 Roche Group Business Overview

11.6.3 Roche Group Chronic Obstructive Pulmonary Disease Introduction

11.6.4 Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.6.5 Roche Group Recent Developments

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Chronic Obstructive Pulmonary Disease Introduction

11.7.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.7.5 Pfizer Recent Developments

11.8 Jubilant Pharma Limited

11.8.1 Jubilant Pharma Limited Company Details

11.8.2 Jubilant Pharma Limited Business Overview

11.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Introduction

11.8.4 Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.8.5 Jubilant Pharma Limited Recent Developments

11.9 Almirall

11.9.1 Almirall Company Details

11.9.2 Almirall Business Overview

11.9.3 Almirall Chronic Obstructive Pulmonary Disease Introduction

11.9.4 Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.9.5 Almirall Recent Developments

11.10 Horizon Pharma

11.10.1 Horizon Pharma Company Details

11.10.2 Horizon Pharma Business Overview

11.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Introduction

11.10.4 Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.10.5 Horizon Pharma Recent Developments

11.11 Boehringer Ingelheim

11.11.1 Boehringer Ingelheim Company Details

11.11.2 Boehringer Ingelheim Business Overview

11.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Introduction

11.11.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023)

11.11.5 Boehringer Ingelheim Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

GSK

MSD

Sunovion

Novartis

Roche Group

Pfizer Inc

Jubilant Pharma Limited

Almirall

Horizon Pharma

Boehringer Ingelheim

List of Tables

Table 1. Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Bronchodilators

Table 3. Key Players of Glucocorticoids

Table 4. Key Players of Other

Table 5. Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 6. Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global Chronic Obstructive Pulmonary Disease Market Size by Region (2018-2023) & (US$ Million)

Table 8. Global Chronic Obstructive Pulmonary Disease Market Share by Region (2018-2023)

Table 9. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 10. Global Chronic Obstructive Pulmonary Disease Market Share by Region (2024-2029)

Table 11. Chronic Obstructive Pulmonary Disease Market Trends

Table 12. Chronic Obstructive Pulmonary Disease Market Drivers

Table 13. Chronic Obstructive Pulmonary Disease Market Challenges

Table 14. Chronic Obstructive Pulmonary Disease Market Restraints

Table 15. Global Chronic Obstructive Pulmonary Disease Revenue by Players (2018-2023) & (US$ Million)

Table 16. Global Chronic Obstructive Pulmonary Disease Revenue Share by Players (2018-2023)

Table 17. Global Top Chronic Obstructive Pulmonary Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease as of 2022)

Table 18. Global Chronic Obstructive Pulmonary Disease Industry Ranking 2021 VS 2022 VS 2023

Table 19. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease Revenue (CR5 and HHI) & (2018-2023)

Table 20. Global Key Players of Chronic Obstructive Pulmonary Disease, Headquarters and Area Served

Table 21. Global Key Players of Chronic Obstructive Pulmonary Disease, Product and Application

Table 22. Global Key Players of Chronic Obstructive Pulmonary Disease, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023) & (US$ Million)

Table 25. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2018-2023)

Table 26. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 27. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2024-2029)

Table 28. Global Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023) & (US$ Million)

Table 29. Global Chronic Obstructive Pulmonary Disease Revenue Share by Application (2018-2023)

Table 30. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 31. Global Chronic Obstructive Pulmonary Disease Revenue Share by Application (2024-2029)

Table 32. North America Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023) & (US$ Million)

Table 33. North America Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029) & (US$ Million)

Table 34. North America Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023) & (US$ Million)

Table 35. North America Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029) & (US$ Million)

Table 36. North America Chronic Obstructive Pulmonary Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. North America Chronic Obstructive Pulmonary Disease Market Size by Country (2018-2023) & (US$ Million)

Table 38. North America Chronic Obstructive Pulmonary Disease Market Size by Country (2024-2029) & (US$ Million)

Table 39. Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023) & (US$ Million)

Table 40. Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029) & (US$ Million)

Table 41. Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023) & (US$ Million)

Table 42. Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029) & (US$ Million)

Table 43. Europe Chronic Obstructive Pulmonary Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2018-2023) & (US$ Million)

Table 45. Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2024-2029) & (US$ Million)

Table 46. China Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023) & (US$ Million)

Table 47. China Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029) & (US$ Million)

Table 48. China Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023) & (US$ Million)

Table 49. China Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029) & (US$ Million)

Table 50. Asia Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023) & (US$ Million)

Table 51. Asia Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029) & (US$ Million)

Table 52. Asia Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023) & (US$ Million)

Table 53. Asia Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029) & (US$ Million)

Table 54. Asia Chronic Obstructive Pulmonary Disease Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 55. Asia Chronic Obstructive Pulmonary Disease Market Size by Region (2018-2023) & (US$ Million)

Table 56. Asia Chronic Obstructive Pulmonary Disease Market Size by Region (2024-2029) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2018-2023) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2024-2029) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2018-2023) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2024-2029) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 62. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2018-2023) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2024-2029) & (US$ Million)

Table 64. AstraZeneca Company Details

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Chronic Obstructive Pulmonary Disease Product

Table 67. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 68. AstraZeneca Recent Developments

Table 69. GSK Company Details

Table 70. GSK Business Overview

Table 71. GSK Chronic Obstructive Pulmonary Disease Product

Table 72. GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 73. GSK Recent Developments

Table 74. MSD Company Details

Table 75. MSD Business Overview

Table 76. MSD Chronic Obstructive Pulmonary Disease Product

Table 77. MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 78. MSD Recent Developments

Table 79. Sunovion Company Details

Table 80. Sunovion Business Overview

Table 81. Sunovion Chronic Obstructive Pulmonary Disease Product

Table 82. Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 83. Sunovion Recent Developments

Table 84. Novartis Company Details

Table 85. Novartis Business Overview

Table 86. Novartis Chronic Obstructive Pulmonary Disease Product

Table 87. Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 88. Novartis Recent Developments

Table 89. Roche Group Company Details

Table 90. Roche Group Business Overview

Table 91. Roche Group Chronic Obstructive Pulmonary Disease Product

Table 92. Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 93. Roche Group Recent Developments

Table 94. Pfizer Company Details

Table 95. Pfizer Business Overview

Table 96. Pfizer Chronic Obstructive Pulmonary Disease Product

Table 97. Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 98. Pfizer Recent Developments

Table 99. Jubilant Pharma Limited Company Details

Table 100. Jubilant Pharma Limited Business Overview

Table 101. Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product

Table 102. Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 103. Jubilant Pharma Limited Recent Developments

Table 104. Almirall Company Details

Table 105. Almirall Business Overview

Table 106. Almirall Chronic Obstructive Pulmonary Disease Product

Table 107. Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 108. Almirall Recent Developments

Table 109. Horizon Pharma Company Details

Table 110. Horizon Pharma Business Overview

Table 111. Horizon Pharma Chronic Obstructive Pulmonary Disease Product

Table 112. Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 113. Horizon Pharma Recent Developments

Table 114. Boehringer Ingelheim Company Details

Table 115. Boehringer Ingelheim Business Overview

Table 116. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product

Table 117. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Business (2018-2023) & (US$ Million)

Table 118. Boehringer Ingelheim Recent Developments

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Chronic Obstructive Pulmonary Disease Market Share by Type: 2022 VS 2029

Figure 3. Bronchodilators Features

Figure 4. Glucocorticoids Features

Figure 5. Other Features

Figure 6. Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 7. Global Chronic Obstructive Pulmonary Disease Market Share by Application: 2022 VS 2029

Figure 8. Prevention Case Studies

Figure 9. Diagnostic Case Studies

Figure 10. Treatment Case Studies

Figure 11. Chronic Obstructive Pulmonary Disease Report Years Considered

Figure 12. Global Chronic Obstructive Pulmonary Disease Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 13. Global Chronic Obstructive Pulmonary Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global Chronic Obstructive Pulmonary Disease Market Share by Region: 2022 VS 2029

Figure 15. Global Chronic Obstructive Pulmonary Disease Market Share by Players in 2022

Figure 16. Global Top Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease as of 2022)

Figure 17. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Revenue in 2022

Figure 18. North America Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 19. North America Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

Figure 20. North America Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

Figure 21. North America Chronic Obstructive Pulmonary Disease Market Share by Country (2018-2029)

Figure 22. United States Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Canada Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe Chronic Obstructive Pulmonary Disease Market Size YoY (2018-2029) & (US$ Million)

Figure 25. Europe Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

Figure 26. Europe Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

Figure 27. Europe Chronic Obstructive Pulmonary Disease Market Share by Country (2018-2029)

Figure 28. Germany Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. France Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. U.K. Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Italy Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Russia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Nordic Countries Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. China Chronic Obstructive Pulmonary Disease Market Size YoY (2018-2029) & (US$ Million)

Figure 35. China Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

Figure 36. China Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

Figure 37. Asia Chronic Obstructive Pulmonary Disease Market Size YoY (2018-2029) & (US$ Million)

Figure 38. Asia Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

Figure 39. Asia Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

Figure 40. Asia Chronic Obstructive Pulmonary Disease Market Share by Region (2018-2029)

Figure 41. Japan Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. South Korea Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. China Taiwan Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Southeast Asia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. India Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Australia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Size YoY (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Share by Type (2018-2029)

Figure 49. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Share by Application (2018-2029)

Figure 50. Middle East, Africa, and Latin America Chronic Obstructive Pulmonary Disease Market Share by Country (2018-2029)

Figure 51. Brazil Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Mexico Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Turkey Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Saudi Arabia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Israel Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. GCC Countries Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 58. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 59. MSD Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 60. Sunovion Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 61. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 62. Roche Group Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 63. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 64. Jubilant Pharma Limited Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 65. Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 66. Horizon Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 67. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2018-2023)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Family Asthma Management Product Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33S10320

Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Global Disposable Oropharyngeal Airway Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25D8684

Wed Mar 20 00:00:00 UTC 2024

Add to Cart

Global PC-Based Spirometer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37U6932

Wed Mar 20 00:00:00 UTC 2024

Add to Cart

Global Respiratory Assistance Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24S8616

Wed Mar 20 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions